1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Prostate cancer risk-associated single-nucleotide polymorphism affects prostate-specific antigen glycosylation and its function
- 2018
- Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival
- 2017
- Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer
- 2016
- Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels.
- 2014
- Genetic Variation in KLK2 and KLK3 Is Associated with Concentrations of hK2 and PSA in Serum and Seminal Plasma in Young Men
- 2012
- Evaluation of Multiple Risk-Associated Single Nucleotide Polymorphisms Versus Prostate-Specific Antigen at Baseline to Predict Prostate Cancer in Unscreened Men
- 2010
- Polymorphisms at the Microseminoprotein-beta Locus Associated with Physiologic Variation in beta-Microseminoprotein and Prostate-Specific Antigen Levels
- Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer.
- A Common Prostate Cancer Risk Variant 5 ' of Microseminoprotein-beta (MSMB) Is a Strong Predictor of Circulating beta-Microseminoprotein (MSP) Levels in Multiple Populations
- Susceptibility Loci Associated with Prostate Cancer Progression and Mortality